LY3015014

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LY3015014, covering 2017-06-21 to 2019-04-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol [Phase 1]